La Jolla, Calif., Jan. 20, 2026 — Fight Colorectal Cancer announced today that Chief Executive Officer Anjee Davis will speak at the Annual Liquid Biopsy for Precision Oncology Summit, taking place Feb. 3–5, 2026, in La Jolla, Calif. The international summit convenes leaders from biopharma, diagnostics, academia, regulators, and patient advocacy to advance the integration of liquid biopsy technologies into oncology drug development and clinical care.
Davis will participate in a session entitled, “Championing Policy and Patient Centered Care to Advance Liquid Biopsy in Practice,” emphasizing the critical role of patient-centered evidence, equitable access, and education in translating precision oncology innovations into real-world impact for people with cancer
“Liquid biopsy is clearly clinically valuable, but too many patients still are not benefiting in a consistent way,” Davis said. “The barriers are not about the science. They are about implementation. Access to liquid biopsy looks very different in community settings compared with academic centers. I really appreciate the opportunity to be a part of this important discussion during this year’s summit.”
The Liquid Biopsy for Precision Oncology Summit celebrates its 10th anniversary in 2026, marking a decade of progress in biomarker science, regulatory alignment, and clinical adoption. The meeting will host more than 250 experts and feature discussions on circulating tumor DNA (ctDNA), minimal residual disease (MRD), regulatory pathways, reimbursement, and the future of precision medicine across cancer types
Daad Abighanem, a Fight CRC research advocate, will be the first patient to speak at this summit, bringing the patient’s voice to open discussions on the real-world impact of liquid biopsy technologies.
Fight CRC’s participation underscores the organization’s continued commitment to ensuring that cutting-edge science translates into longer, better lives for all patients, with colorectal cancer patients fully represented in the precision oncology revolution.
About Fight Colorectal Cancer
Fight Colorectal Cancer (Fight CRC) is a leading patient-empowerment and advocacy organization in the United States, providing balanced and objective information on colon and rectal cancer research, treatment, and policy. We are relentless champions of hope, focused on funding promising, high-impact research endeavors while equipping advocates to influence legislation and policy for the collective good. Learn more at FightCRC.org.
Contact
Elizabeth Jordan
Fight Colorectal Cancer
703-548-1225
elizabeth@fightcrc.org